#India #Mumbai #CDMO #Piramal Pharma #Quality Control

Piramal Pharma Solutions' Exceptional Quality Performance

In a remarkable demonstration of its commitment to excellence, Piramal Pharma Solutions has successfully completed over 200 client audits and secured more than 70 regulatory approvals around the globe in the past fiscal year. This achievement highlights the effectiveness of the company’s long-term quality strategy, which is centered on stringent compliance with industry standards and an unwavering dedication to operational efficiency.

A Commitment to Quality Governance

The results from these audits are not merely numbers; they illustrate the robust framework Piramal has implemented for quality governance. At the core of this strategy is a commitment to continuous improvement, promoting a culture of high standards among its teams, and the swift adaptation to evolving regulatory requirements.

Rashida Najmi, the Chief Quality Officer at Piramal Pharma Limited, emphasized that quality is intricately woven into the fabric of the company's daily operations. This strategic focus ensures that preparation for audits is a continuous process rather than a one-time event. The ability to maintain high standards in quality is crucial for providing reliable and safe treatments to patients worldwide.

Key Elements of the Quality Strategy

Piramal’s quality strategy incorporates several critical components:

• - Predictive Tools: These assess site readiness and compliance levels to preemptively address any potential issues.
• - Customized Systems: Designed to enhance efficiency while minimizing costs associated with poor quality.
• - Error-Free Execution Initiatives: Implementing programs like “RESOLVE” aims to facilitate error-free processes right from the initial trial in manufacturing laboratories. This includes real-time review of batch records and heightened operational vigilance.

Additionally, ongoing training programs are paramount; they aim to better prepare staff for audits and enhance their relationships with regulatory authorities, thereby strengthening the quality capabilities across the board.

Digital Transformation in Quality Management

The integration of digital platforms has significantly bolstered the quality processes at Piramal Pharma Solutions. Through tools like eLab, they have managed to digitize their quality control labs, automate testing processes, and consequently, reduce errors. This technological adoption not only improves accuracy but also enhances execution timelines.

Moreover, the company has embraced solutions such as exForms for digitizing GxP forms, which ensures compliance with the ALCOA principles, thus improving accessibility, speeding up validation processes, and preparing for audits without needing a significant overhaul of operations.

The AI-driven tool iAssist stands out among its innovations, designed to enrich the efficiency and rigor of investigatory processes. By structuring investigation outcomes and diminishing the manual workload, the tool contributes to a smarter operational framework.

The Future of Piramal Pharma Solutions

As Piramal Pharma Solutions continues to impress with its audit results and regulatory compliance, the organization is poised to solidify its stature as a trusted global CDMO (Contract Development and Manufacturing Organization). By upholding its commitment to delivering safe and effective treatments, the company not only advocates for the highest standards of pharmaceutical quality but also reinforces its role as a key player in the global healthcare landscape.

In summary, Piramal Pharma’s achievements in client audits and regulatory approvals not only reaffirm its strategic quality initiatives but also point toward a future where quality and compliance remain the cornerstone of its operations, ultimately benefiting patients across the globe.